A Cyclized Bivalent Aptamer-Based Protein Degrader Targeting Receptor Tyrosine Kinases Overcomes Resistance to Inhibitors in Lung Cancer
- Journal:
- ACS Nano
- Published:
- Affiliations:
- 3
- Authors:
- 7
| Institutions | Authors | Share |
|---|---|---|
| State Key Laboratory of Chemo and Biosensing, HNU, China | 0.90 | |
| Zhejiang Cancer Hospital (ZJCH), China | 0.05 | |
| Hangzhou Institute of Medicine (HIM), CAS, China | 0.05 |